The pathophysiology of erectile dysfunction post radical prostatectomy is not clearly clarified, and the low efficacy of traditional PDE5i treatment remains a major complaint in contemporary practice. This study aimed to demonstrate phenotypic modulation in bilateral cavernous nerve injury (BCNI) rats within 7 days, and subsequently validate gene therapy with Myocardin (Mycod) by maintaining a contractile phenotype in corpus cavernosum smooth muscle cells. Initially, 36 male rats were randomly divided into BCNI and negative control (NC) groups for histological and phenotypic molecular measurements at 3, 5, and 7 days. Afterwards, an additional 30 rats received a single intra-cavernous injection of 50 lL PBS, Ad-Myocd (1 9 10 11 pfu/ml) or Ad-vector for 10 animals each, namely the NC+PBS, BCNI+Ad-Myocd, and BCNI+Ad-vector groups. Finally, the validity and mechanism of Myocd transfection was explored at 21 days in vivo and 48 h in vitro. Western blotting showed canonical declines in Myocd, a-SMA, and Calponin expression, as well as elevated Osteopontin (OPN) expression, before corporeal morphological and SM-to-collagen ratio changes at day 5 after injury. Overexpression of Myocd maintained the contractile phenotype of corpus cavernosum smooth muscle cells, ameliorated bilateral cavernous nerve injury rat erectile dysfunction, as well as promoted cell contractility and suppressed proliferative capacity. Simultaneously, confocal imaging revealed up-regulation and co-localization of serum response factor in gene-transferred cells. In conclusion, our study is the first to investigate corpus cavernosum smooth muscle cells phenotypes in the early stages of cavernous injury model rats, and Myocd reversed phenotypic modulation by activating serum response factor. The experimental results demonstrated the validity of gene therapy for erectile dysfunction.
INTRODUCTION
Radical prostatectomy (RP) is the primary treatment for patients with localized prostate cancer. However, the incidence rate of erectile dysfunction (ED) post-operation remains as high as 30-87% (Liao et al., 2015) . Currently, the pathophysiology of RP-ED has not been well-elucidated (Weyne et al., 2015b) . Several reports have demonstrated that lesions to neurovascular bundles through partial or total cavernous nerve resection, or by stretching and thermal injury of the nervous fibers during nerve-sparing surgeries leading to a condition called 'neuropraxia', which may be the main cause of ED (Cohen & Glina, 2015; Lin et al., 2015) . However, the actual changes within the cavernous body need to be further investigated.
Phenotypic switching in vascular smooth muscle cells (VSMCs), defined as the ability to transform from the contractile phenotype to the synthetic phenotype reversibly (Lacolley et al., 2012) , has been studied in depth and has been shown to be one of the most important molecular mechanisms underlying multiple cardiovascular diseases, including atherosclerosis (AS), hypertension, and in-stent restenosis. (Owens, 2004) . Importantly, contractile phenotype cells express biomarkers including alpha-smooth muscle actin (a-SMA), Calponin, smooth muscle myosin heavy chain (SMMHC), and Smoothelin, while synthetic phenotype cells express osteopontin (OPN) and proliferating cell nuclear antigen (PCNA), among others (Zhang et al., 2016) . During in vitro cell experiments, platelet-derived growth factor BB (PDGF-BB) has often been used as a synthetic phenotype stimulator because of its mitogenic effect when bound to the PDGF receptor (Chen et al., 2006) . In addition to apoptosis and fibrosis, the corpus cavernosum smooth muscle cells (CCSMCs) also underwent phenotypic modulation in diabetic ED rats, which was first demonstrated by our previous study . Recently, Yang, et al. investigated the existence of smooth muscle cell modulation after 12 weeks in bilateral cavernous neurectomy (BCNR) rats (Yang et al., 2014) . However, there are no studies investigating phenotypic changes in the early stages of bilateral cavernous nerve injury (BCNI) rats, or their relationship with ED.
Myocardin (Myocd), a potent transcriptional factor encoding SMC-specific genes, is a well-established regulator of SMC differentiation (Chen et al., 2002) and maintains homeostasis of the vasculature and gastrointestinal and genitourinary tracts (Huang et al., 2015) . Conventionally, Myocd is believed to exert its biological function through binding to serum response factor (SRF) and forming a ternary complex with the CArG box (Wang et al., 2001) . In this study, we hypothesized the participation of CCSMC phenotypic modulation in the early stages of ED rats that underwent cavernous nerve injury, and aimed to validate the feasibility of ameliorating erectile dysfunction by maintenance of the contractile phenotype via gene transfer of Myocd.
METERIALS AND METHODS

Animals and experimental design
Male Sprague-Dawley rats with normal erectile function were obtained from the Experimental Animal Center of Southern Medical University. All experimental protocols were performed under the Institutional Animal Care and Use Committeeapproved guidelines at our institution.
The animal study was divided into two parts. In the first part, 36 rats were randomly assigned to BCNI or negative control (NC) groups. To investigate the time-dependent changes of the cavernous body, subgroups at 3, 5, and 7 days post-operation were established with six rats each. The animal models were established as previously reported (Fandel et al., 2012) . Briefly, under anesthetization via an intraperitoneal injection of sodium pentobarbital (45 mg/kg), cavernous nerves (CNs) were exposed bilaterally through a lower-abdominal incision, and a crush injury was performed by application of a 5 mm diameter haemostatic clamp for 2 min. In the NC group, no further surgical procedures were performed, and the abdomen was closed. Subsequently, rats were sacrificed 3, 5, and 7 days later, after intracavernosal pressure (ICP) and mean arterial pressure (MAP) tests. The corporeal bodies were prepared for molecular examination to confirm the phenotypic change timepoint.
In the second part, 30 rats were randomly divided into three equal groups, namely NC+PBS, BCNI+Ad-Myocd, and BCNI+Ad-vector. A single intra-cavernous injection of 50 lL PBS, AdMyocd (purified adenovirus with the Myocd gene, 1 9 10 11 pfu/ ml, purchased from Hanbio Co., Shanghai, China), or adenovirus with an empty vector was given to the corresponding rats. 21 days later, all animals were anesthetized for ICP and MAP measurements and were killed thereafter. The penises were harvested, weighed, and processed for further study.
Penile erection evaluation
Penile erectile function was assessed using ICP and MAP tests as previously reported (Liao et al., 2015) . The CNs were exposed and a bipolar, stainless steel electrode was used for nerve stimulation. Subsequently, the right penile crus was located and a 25-G needle containing 100 U/ml of heparin solution connected to polyethylene-50 tubing was inserted for the measurement of ICP with an MP150 pressure transducer (Biopac Systems Inc., Goleta, California, USA) and AcqKnowledge â 4.4 software (Biopac Systems Inc. Goleta, California, USA). The stimulus parameters were as follows: amplitude (5 mA), frequency (20 Hz), pulse width (0.2 ms), and duration (60 sec). The erectile evaluation was measured as maximal ICP, change in ICP (DICP), and the ratio of change in ICP and MAP (DICP/MAP). The ICP operator was blinded to the allocation of animals into different treatment groups.
Histology
Freshly dissected tissues were fixed and prepared for histological examinations. H&E and Masson's trichrome staining and immunochemistry (IHC) were performed according to established protocols and previous reports (Cho et al., 2015) . Sections were cut at 4 lm thickness and incubated with anti-Myocd (1 : 100, catalog # ab203614, Abcam, Cambridge, UK) and anti-a-SMA (1 : 50, catalog # sc-53015, Santa Cruz, California, USA) antibodies. Digital images were acquired with an Olympus microscope, and the SM-to-collagen ratios, based on Masson's trichrome staining, were evaluated using Image-Pro Plus 6.0.
Cell culture, gene transfer, and PDGF-BB stimulation
CCSMCs were isolated and cultured using a tissue explantadherent method as previously described . Immunofluorescence was performed for cell identification with an anti-calponin antibody (1 : 100, catalog # sc-58707, Santa Cruz, USA) from passage three cells. Afterwards, CCSMCs were transfected with Ad-vector, Ad-Myocd (MOI: 1 : 50, 1 9 10 10 pfu/ml, Hanbio Co. Shanghai, China) or PDGF-BB (Phenotypic modulation positive control, 20 ng/ml, Peprotech, Rocky Hill, California USA). 48 h later, cells were harvested for further studies. All of the following cell experiments were performed in triplicate.
Immunofluorescent staining and confocal microscopy
CCSMCs were seeded and grown on glass coverslips (Wang et al., 2014) . After the aforementioned treatments, the cells were fixed with 4% paraformaldehyde and incubated with 0.25% triton X-100/1% bovine serum albumin (BSA)/PBS. The primary antibodies, a-SMA (1 : 50), Calponin (1 : 100), Myocd (1 : 100, catalog # ab22073, Abcam, Cambridge, UK) and SRF (1 : 50, catalog # 5147, CST, Danvers, Massachusetts, USA), were incubated at 4°C overnight, followed by double-staining of secondary antibodies (1 : 50, catalog # BS10250, 10950, 50950, 11502, Bioworld, Visalia, California, USA) with FITC (green) or TRITC (red) at room temperature for 1 h, protected from light. 4 0 ,6-diamidino-2-phenylindole (DAPI, Abcam) staining was introduced to locate the cell nucleus. The contractile proteins a-SMA and Calponin and the molecular co-localization of Myocd and SRF were detected with an Olympus laser-scanning confocal microscope.
EdU and CCK8 cell proliferative assay 5-Ethynal-2 0 -deoxyuridine (EdU, RiboBio, Guangzhou, China) and Cell Counting Kit (CCK8, Dojindo, Japan) assays were performed using standard procedures according to the manufacturer's instructions to verify proliferative capacities. For the EdU test, proliferating cells were double-stained with Hoechst 33342 (blue) and EdU (red), while quiescent cells were stained with Hoechst only. The numbers of total and EdU+ cells were counted, respectively, in 3 independent fields at 4009 magnification in every cultured well. In the CCK8 reactions, cell proliferation rates were determined by OD values read with a multimode microplate reader at 1, 2, 4, 24 and 48 h after gene or PDGF-BB stimulation. Time growth-curves were created with GraphPad Prism 5 software.
Collagen gel lattice contraction assay A modified in vitro cell contractility assay was performed as previously described (Kropp et al., 1999) . Briefly, differently treated smooth muscle cells at a density of 2 9 10 5 cells/ml were mixed with solubilized type I collagen (Sigma, St. Louis, Missouri, USA) to form a cell-collagen suspension at a final concentration of 1 mg/ml. 200 ll of suspension were dropped in a 35-mm culture dish immediately and incubated in growth medium for 5 days before the cell-collagen lattice was mechanically released from the underlying plastic substrate. The lattice was subsequently exposed to serum-free Dulbecco's modified Eagle's medium (DMEM), DMEM plus 10% fetal bovine serum (FBS) or DMEM plus 1 lM calcium ionophore (Ca-Ionophore, Sigma, USA). The diameters before releasing the lattice and 10 min after the various exposures were recorded for relative percent contraction. The serum-free DMEM served as a negative control, while the FBS served as a positive control.
qRT-PCR analysis Total RNA was prepared from cultured cells and was used for Real-time Quantitative PCR analyses. Primer sequences were as follows: b-Actin: GATCAAGATCATTGCTCCTCCTG (sense), AGGGTGTAAAACGCAGCTCA (anti-sense); Myocd: CTTGCA-GATGACCTCAACGA (sense), TCACGGAAGAATCCATAGGC (anti-sense); a-SMA: TTCAATGTCCCTGCCATGTA (sense), CAT CTCCAGAGTCCAGCACA (anti-sense); Calponin: ATCATTGGC CTACAGATGGGC (sense), AGCGTGTCACAGTGTTCCAT (antisense); OPN: CCAGCCAAGGACCAACTACA (sense), AGTGTTTGC TGTAATGCGCC (anti-sense); SRF: ACCAGCTTCACTCTCATGCC (sense), TGCATGGGGACTAGGGTACA (anti-sense).
Western blot analysis
Western blotting was performed for protein expression analysis as described previously . The primary The cavernous nerve injuries led to a marked decline in the maximum ICP and DICP/MAP. The stimulus was maintained for 60s and is indicated by a solid bar. (B) and (C) H&E and Masson's trichrome staining showed no significant differences in morphology and SM-to-collagen ratio among the different groups. (D) Significantly reduced Myocd, a-SMA, and Calponin expression, and increased OPN expression, was detected in BCNI 5d and BCNI 7d groups by western blot. Taking the unchanged morphology and smooth muscle content together, CCSMCs in BCNI rats underwent molecular changes consistent with 'phenotypic modulation'. Animals tested: n = 6. *p < 0.05. [Colour figure can be viewed at wileyonlinelibrary.com].
800 Andrology, 2017, 5, 798-806 antibodies and dilutions are listed below: Myocd, 1 : 400 (catalog # ab22073, Abcam); a-SMA, 1 : 400; Calponin, 1 : 400; OPN, 1 : 1000 (catalog # ab8448, Abcam, Cambridge, UK); b-actin and Flag, 1 : 8000 (catalog # RM2001, # RM 1002, Ray Antibody Biotech, Beijing, China). Secondary antibodies were purchased from Abbkine Inc. (catalog # A21010, # A21020, USA) and diluted at 1 : 30,000. The recombinant Adenovirus we used contained 39 flag, therefore a flag antibody was used as a supplementary marker to confirm cell and penis transfection efficiency.
Statistical analysis
Statistical analysis was performed with the SPSS version 21.0 software for Windows. Results were recorded as mean AE SEM. Treatment groups were compared using one-way ANOVA, and relative mRNA expressions were analyzed through the Student's t-test. The Univariate General linear Model with Fixed Factors of time and group was introduced to test the CCK8 results. The statistical significance was determined at the 5% confidence level (p < 0.05).
RESULTS
Erectile dysfunction but no histological changes in BCNI rats within 7 days
The three subgroups at 3, 5, and 7 days in BCNI rats showed a remarkable decline in the maximum ICP compared with the NC group (Fig. 1A) . DICP/MAP in the BCNI groups was significantly lower than in the NC group. There were no differences in ICP among the NC groups, as well as in MAP among all the BCNI and NC groups (data not shown). Meanwhile, H&E and Masson's trichrome staining revealed no morphological or SM-to-collagen ratio changes within 7 days in the surgical groups and the controls (Fig. 1B and C) .
Phenotypic modulation of BCNI rat CCSMCs at day 5
Western blotting revealed a marked decrease in Myocd, a-SMA, and Calponin expression along with elevated OPN expression at day 5 after modeling (Fig. 1D) . Given the unchanged morphology and smooth muscle content, taken together the CCSMCs in BCNI rats underwent molecular changes consistent with phenotypic modulation. Therefore, we chose day 5 for the intra-cavernous injection of PBS, AdMyocd, or Ad-vector into corresponding rats, when changes in the phenotypic biomarkers were first observed, to maintain the phenotype and certify the efficiency of gene therapy.
Myocardin gene therapy maintained the contractile phenotype
As shown in Fig. 2A , Flag was introduced to confirm gene transfection. Twenty onedays after injection, Myocd and contractile smooth muscle marker (a-SMA, Calponin) expression levels in the gene-transferred group were not different from the control rats and were significantly higher than in the BCNI+Ad-vector group. The CCSMC synthetic marker OPN was highly expressed in BCNI+Ad-vector rats compared with the other Figure 2 Maintenance of the CCSMC contractile phenotype ameliorated erectile dysfunction and increased smooth muscle content in BCNI rats. (A) PBS, Ad-Myocd, Ad-vector were intracavernously injected at day 5 after injury. 21 days later, flag was introduced to confirm the gene transfection efficiency. Myocd, a-SMA, Calponin expression showed no difference from the control rats and were significantly higher than in the BCNI+Ad-vector group. Combined with the reduction in OPN expression, Myocd reversed the phenotypic modulation in BCNI rats. (B) Transfection of Myocd significantly improved the maximum ICP and DICP/MAP results of the cavernous nerve injury rats after 21 days, although they were still lower than in the NC group. (C) A thinner smooth muscle layer and disordered and discontinuous cavernous sinuses were observed in both BCNI rat groups, with more severe changes in the Advector group. (D) In Masson's trichrome staining images, the Ad-Myocd group maintained a more 'normal' SM-to-collagen ratio compared to the Ad-vector group. (E) IHC revealed relatively higher expression of Myocd and restoration of a-SMA in gene-transferred rats (1009 magnification, upper row; 4009 magnification, lower row). Lower rows represent enhanced magnification of red rectangle boxes in upper rows. Animals tested: n = 10. *p < 0.05. [Colour figure can be viewed at wileyonlinelibrary.com].
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Erectile dysfunction and histology improvement in genetransferred rats Figure 2B showed partial recovery of the maximum ICP in BCNI+Ad-Myocd rats at the 21st day compared with the BCNI+Ad-vector group. However, the DICP/MAP in gene therapy rats was still lower than in the control group. Simultaneously, H&E staining revealed a thinner smooth muscle layer, and disordered and discontinuous cavernous sinuses in two CN-injured rats. However, as shown in Fig. 2C , Myocd treatment also partly sustained the aforementioned morphological features. In Masson's trichrome staining, the SM-to-Collagen ratio decreased in both BCNI groups, with a more significant reduction in the vector rats (p < 0.05, Fig. 2D ). Moreover, IHC suggested considerably greater expression of Myocd and a-SMA in the NC+PBS and BCNI+Ad-Myocd groups under 1009 and amplified 4009 microscopy fields (Fig. 2E ).
CCSMC identification
In Fig. 3A , pictures are shown of primary cells emerging from the corpora tissues and passaged cells growing in a whirlpoollike pattern. Over 95% of the cultured cells were identified by immunofluorescence (IF) with Calponin (Fig. 3B) , suggesting highly pure CCSMCs for the following experiments.
Myocardin promoted a-SMA and Calponin expression and suppressed OPN expression Overexpression of Myocd was shown for mRNA and protein ( Fig. 3C and D) . Flag was detected in Ad-Myocd cells to confirm gene transfection. Compared with the Ad-vector (control) cells, 802 Andrology, 2017, 5, 798-806 increased levels of SMC contractile proteins, a-SMA and Calponin, and decreased synthetic marker, OPN, were found in the Ad-Myocd group, with a completely reversed trend in the PDGF-BB group, revealing the opposite role of the two treatments in remodeling the CCSMCs. Figure 3E Reduced proliferative capacity and enhanced contractility
As shown in Fig. 4A , the cell density and EdU+ cell ratios for the Myocd-transfected group were markedly reduced. PDGF-BB significantly increased the EdU+ cell ratio compared with other groups. In Fig. 4B , CCK8 assays showed relatively equivalent growth activities within 4 h among the three groups. Afterwards, PDGF-BB significantly accelerated the cell growth, while Myocd slowed down the proliferation. For the cell contractility assay, after different stimulations of DMEM, DMEM plus 10% FBS or DMEM plus 1 lM Ca-Ionophore, the diameters of different cellcollagen lattices were measured and calculated (shown in Fig. 4C are the Ca-Ionophore stimulation images). Taken together, Myocd inhibited the CCSM cell phenotypic switch.
SRF was up-regulated and co-localized with Myocd
SRF mRNA and protein expression were upregulated ( Fig. 5A  and B) . Confocal microscopy revealed SRF mainly located in the nucleus of CCSMCs (green). Overexpression of Myocd (red) relocalized the fluorescence intensity of SRF in the cytoplasm. In addition, SRF was co-localized with Myocd both in the nucleus and the cytoplasm, indicating interactions between these two molecules.
DISCUSSION
In this study, we established a canonical BCNI rat model and characterized the histological and molecular features over time. H&E and Masson's trichrome staining showed no remarkable changes within one week, while western blots revealed reduced contractile phenotypic markers, a-SMA and Calponin, and an elevated synthetic element, OPN, indicating for the first time that CCSMC phenotypic modulation occurred by day 5 following modeling. We demonstrated the validity and mechanism of Myocardin (Myocd) gene therapy after 21 days in vivo and 48 h in vitro. Myocd maintained the contractile phenotype of CCSMCs, ameliorated BCNI rat erectile dysfunction, promoted cell contractility and suppressed proliferative capacity, possibly through activating SRF, which is consistent with our previous report in diabetic ED rats and other observations in VSMCs (Bell et al., 2008) .
Despite the utilization of new surgical facilities and techniques, the inevitable stretching, crushing or coagulation on or in proximity to the neurovascular bundles can cause transient or lasting interruption between the pelvic nerves and the corporal body. Several investigations have been undertaken to clarify the occurrence of ED post-nerve-sparing RP (NS-RP), especially concerning the hypothesis of 'neuropraxia'. The denervated cavernosum subsequently develops apoptosis and fibrosis, resulting in poor responses to the newly regenerative peripheral nerves in later periods (Weyne et al., 2015a) . Corporal veno-occlusive dysfunction (CVOD) has also been proposed to develop Figure 4 Reduced proliferative capacity and enhanced contractility of Myocd-transferred cells. (A) EdU assay identified proliferating cells 48 h after stimulation. Under 4009 magnification, the EdU+ (red) cell ratio was determined and declines were identified for the PDGF-BB and vector compared to Myocd treatment groups. (B) CCK8 assays confirmed the proliferative capacity trend of the three groups, although no differences among these cells within 4 h after exposure were observed. (C) Histogram of cellcollagen lattices at 10 min after DMEM, DMEM plus 10% FBS or DMEM plus Ca-Ionophore stimulation. Myocd enhanced the cell contraction in both the DMEM plus 10% FBS and DMEM plus Ca-Ionophore treatments, while the phenotypechanged cells induced by PDGF-BB lost some of their contractive capability. There was no difference among the groups with DMEM stimulation. Cell experiments performed: n = 3. *p < 0.05. [Colour figure can be viewed at wileyonlinelibrary.com].
progressively after surgery, leading to venous leak and subsequent ED (Kovanecz et al., 2008) . Thus, the pathophysiology, especially in the early post-operative stages, involved in smooth muscle, endothelial and neurovascular alterations requires intensive research (Weyne et al., 2015b) . Our study provides evidence for CCSMC molecular transformation consistent with a characterization of 'phenotypic modulation' before corporeal morphological and SM-to-collagen ratio changes in the early stages of BCNI in model rats.
In cardiovascular systems, VSMC phenotypic modulation is widely accepted as one of the fundamental pathophysiological changes in diseases like hypertension, diabetes, injury, AS and in-stent restenosis (Giordano & Romano, 2011) . This modulation implies that a smooth muscle cell could take on two reversible phenotypes and exert different effects, defined as contractile (also known as differentiate) phenotype and synthetic (proliferative or dedifferentiate) phenotype, respectively, without developing into other cells (Lacolley et al., 2012) . Typically, the differentiated cells sustained good contractility and relaxation with substantial actin cytoskeletal proteins, such as a-SMA (acta2), Calponin, SMMHC, and smoothelin (Davis-Dusenbery et al., 2011). When exposed to pathogenic conditions in vivo or stimulations in vitro, cells were triggered to express synthetic proteins like OPN and PCN, conferring the ability to proliferate, migrate, promote extra cellular matrix (ECM) production, inflammatory signals, and/or calcification, which is one of several compensatory mechanisms to prevent damage but later enlarges the vascular intima thickness and increases collagen deposition (Zhang et al., 2016) . PDGF-BB is one of the most commonly used stimulators to induce VSMC phenotypic modulation as a result of its mitogenic potential (Kamiyama et al., 2003) . According to our observations, CCSMCs were also induced to possess stronger proliferative capacity but poorer contractility by PDGF-BB at a dose of 20 ng/mL, demonstrating similar effects of PDGF-BB on these two cell types. Collectively, the phenotypic change from contraction to synthesis caused cardiovascular dysfunction, as we previously reported in erectile dysfunction .
Myocd is a smooth muscle and cardiac muscle-specific transcriptional co-factor of SRF. When first discovered in the cardiovascular system in 2001 (Wang et al., 2001) , Myocd was shown to control cardiovascular embryonic development. Knocking out 804 Andrology, 2017, 5, 798-806 Myocd in mice resulted in death at embryonic day 10.5 with cardiac VSMC defects (Morita & Hayashi, 2014) . Recently, it was shown that Myocd plays an indispensable role in the maintenance and homeostasis of the vasculature and gastro-intestinal and genitourinary tracts during postnatal development. Myocd conditionally mutant mice developed remarkable dilation of the stomach, small intestine, bladder, and ureters, attributable to the loss of visceral SMCs disrupting the muscularis mucosa (Huang et al., 2015) . Conventionally, the importance of Myocd was explained by its ability to co-activate SRF and target to the CArG-box, forming a ternary complex, thereby promoting the encoding of SMC cytoskeletal and contractile gene expression, such as smooth muscle 22a and smoothelin-A through SMMHC promoters. As the key regulator of smooth muscle cell phenotype, Myocd was chosen as our target gene.
Although several preventive and therapeutic approaches are available, no specific recommendations have been made for the optimal treatment for RP-ED. In particular, some patients have responded poorly to traditional phosphodiesterase type 5 inhibitors (PDE5i) (Kim & Lee, 2015) . To gain better penile rehabilitation, novel therapeutic strategies have been demonstrated in many animal experiments, preclinical and clinical trials, including cell-based transplantation (Yiou et al., 2016) , antioxidant substance delivery (Zhu et al., 2015) , low intensity extracorporeal shock wave therapy (Li-ESWT) (Jeon et al., 2016) , gene therapy (Lin et al., 2013) , and others. Among them, with the dual abilities to differentiate into target cells and to secrete paracrine effectors, stem cell therapy has been the most popular and has showed promising efficiency in many different ED animal models (Shan et al., 2015) . When it was tested in patients who failed to benefit from traditional therapies, several people showed no response while others demonstrated various onset times ranging from several days to months. However, most of the participants lost their gains several months later (Haahr et al., 2016) . Therefore, the validity and durability of stem cell therapy in the clinic requires further investigation. Additionally, antioxidant and Li-ESWT therapies have been explored in animal experiments, exerting particular influence in anti-inflammatory responses and improving endothelial function (Shan et al., 2016) . In recent years, several studies have highlighted the therapeutic potential of, and the underlying mechanism for, the involvement of endogenous stem cells (SCs) in these two treatments. Rats that underwent injection of EdU for the purpose of tracking endogenous SCs at birth and management of BCNI or pelvic neurovascular injury at 12 weeks were treated with the antioxidant agent icariside II or Li-ESWT . Both the studies reported erectile dysfunction improvement, tissue restoration and more endogenous EdU (+) SCs recruited to the damaged penile areas, implying the probability of self-healing by endogenous SC mobilization and activation.
In this study, we have focused on gene therapy. Unlike other fixed programs, gene therapy has been carried out based on correcting overexpressing or defective genes with genetic engineering, showing better precision and purposiveness toward specific disease processes (Song et al., 2014) . In this study, we successfully validated Myocd transfection to reverse decreased levels of contractile proteins and improve erectile dysfunction through up-regulation of SRF. We used purified adenovirus carrying the Myocd gene with a high viral titer of 1 9 10 11 pfu/ml to ensure effective transfection efficiency. However, as our results were restricted by the use of adenovirus which expresses for at most 3 weeks, the long-term effects of Myocd on CCSMCs were not able to be discovered.
CONCLUSIONS
Collectively, bilateral cavernous nerve injury rat corpus cavernosum smooth muscle cells phenotypic modulation was detected at day 5 after modeling. The gene transfection of Myocardin promoted corpus cavernosum smooth muscle cells contractile protein alpha-smooth muscle actin and Calponin expression and suppressed synthetic element osteopontin expression, as well as ameliorated erectile dysfunction in bilateral cavernous nerve injury rats, likely through activation of serum response factor. Our study is the first to investigate phenotype change in the early stages of cavernous injury in rats, and the experimental results demonstrated the validity of gene therapy for erectile dysfunction.
